Virtual app to support breast and colorectal cancer survivors
Testing the Feasibility of a Virtual Application to Support Breast and Colorectal Cancer Survivors After Completing Primary Treatment
This study will test whether a mobile app helps breast and colorectal cancer survivors after primary treatment manage follow-up care and find community and health-system resources.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Nova Scotia Health Authority Academic / other |
| Drugs / interventions | radiation |
| Locations | 2 sites (Saint John, New Brunswick and 1 other locations) |
| Trial ID | NCT07312786 on ClinicalTrials.gov |
What this trial studies
Developed with SeamlessMD, the intervention is a mobile health application that serves as an information hub delivering timely, evidence-based guidance and links to resources for people after primary cancer treatment. The project is a feasibility implementation at two Atlantic Canadian cancer centres (Halifax QEII and Saint John Regional Hospital) where participants will have access to the app for six months. Researchers will collect user and provider feedback and completion of questionnaires to measure usability, acceptability, and practical issues with deployment. Findings will inform whether the app can be scaled or modified for broader survivorship care.
Who should consider this trial
Good fit: Adults (18+) diagnosed with stage I–III breast or colorectal cancer who completed primary treatment (surgery and/or adjuvant systemic or radiation therapy) between 6 months and 5 years ago and can provide informed consent are ideal candidates.
Not a fit: Patients with metastatic disease, those still within 6 months of completing primary treatment, or people who cannot access or use a smartphone/internet are unlikely to benefit from this intervention.
Why it matters
Potential benefit: If successful, the app could improve survivors' communication with care teams, help people follow recommended surveillance and self-management practices, and connect them to local supports.
How similar studies have performed: Other digital survivorship and care-navigation tools, including SeamlessMD deployments in perioperative and oncology settings, have shown promise for engagement and information delivery, but evidence of large effects on long-term clinical outcomes is still limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults older than 18 years, capable of providing informed consent * Diagnosed with stage I-III breast or colorectal cancer, and have completed primary treatment for their cancer (surgery and/or adjuvant systemic or radiation therapy) 6 months - 5 years ago
Where this trial is running
Saint John, New Brunswick and 1 other locations
- Saint John Regional Hospital — Saint John, New Brunswick, Canada (Not_yet_recruiting)
- Centre for Clinical Research QEII Health Sciences Centre — Halifax, Nova Scotia, Canada (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.